BRÈVE

sur AI/ML Innovations Inc. (CVE:AIML)

AI/ML Innovations Subsidiary Appoints Dr. Mehmet Kosoglu as Regulatory Head

AI/ML Innovations Inc. has announced the appointment of Dr. Mehmet A. Kosoglu as Head of Regulatory at its subsidiary, NeuralCloud Solutions Inc. Dr. Kosoglu brings over 15 years of experience from the FDA, focusing on medical devices and digital health. His role will support the company’s AI-driven cardiac technologies, MaxYield™ and CardioYield™.

Dr. Kosoglu's background as a former FDA reviewer is expected to fortify NeuralCloud’s regulatory strategies as it advances its ECG signal-processing technologies. Prior achievements include obtaining ISO 13485:2016 certification, building the foundation for further medical device development and commercialization.

Paul Duffy, CEO of AIML, highlighted Dr. Kosoglu’s regulatory expertise as a pivotal addition. Dr. Kosoglu's experience with FDA submissions and quality systems will complement NeuralCloud’s efforts to enhance ECG analysis technologies. His insights will aid AIML in navigating regulatory pathways for their products.

R. E.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de AI/ML Innovations Inc.